Skip to content

We are fully committed to innovate therapies and drugs in anaesthesia, pain management, intensive care and neuromodulation

sintetica-image

About us

Established in 1921 and headquartered in Mendrisio, Sintetica is a Swiss pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing.

Sintetica has two production sites, both located in Switzerland, as well as commercial offices in Switzerland and Germany. We employ around 300 people coming from 30 different countries in the world.

Production capacity of our manufacturing plants (per year)

5 mio infusion bags

8 mio vials

90 mio Polypropylene and glass ampoules

Areas of focus

We offer a wide range of products in different therapeutic areas such as anesthesia, pain management, neuromodulation and intensive care.

Sintetica has developed a clear innovation strategy following patient needs and new sustainable pharma trends.

This includes the reformulation of existing molecules for new administration methods, premixed solutions with high stability that are ready to be used by clinicians, the removal of potentially harmful additives such as preservatives and sulphites without affecting quality or shelf life and the re-design of product packaging to improve user experience and enhance safety

We are always looking for solutions that make therapies safer, easier to use, and better for patients and practitioners. We also partner with physicians, academics and Key Opinion Leaders across the world to access the best science and accelerate the development of innovative drugs.

We develop novel drugs and make available life-changing medicines to the largest number of patients and healthcare providers worldwide.

premix

Premixed medicines increase the safety of the therapy, by a direct administration of the product to the patient without any previous dilution, reducing time and complexity of the drug preparation. We enhance drug formulations assuring the fitting of our premix medicines to the current standard of care.

innovating-anaesthesia

Surgical procedures invasivity or duration reduction and increased cost pressures on health systems are leading to a shift toward day surgery. Modern short and medium acting local anesthetics are our One Day Surgery proposal to adapt the length and the conditions of anaesthesia to the novel surgical needs, allowing patients same day safe discharge.

one-day-surgery

painscience

Pain science represents our effort towards a continuous improvement of pain management therapies. These analgesics are primarily used to manage pain in perioperative settings, while also addressing acute and chronic pain of various origins and intensity.

Our portfolio includes a wide range of opioid and non-opioid products, innovative combination of active principles alongside the most established and historically used molecules.

enhance-intrathecal-theraphy

Enhance Intrathecal Therapy is our promise to improve care in the neuromodulation. We develop novel drugs and make available life-changing medicines to the largest number of patients and health care providers world-wide.

Premix

premix

Premixed medicines increase the safety of the therapy, by a direct administration of the product to the patient without any previous dilution, reducing time and complexity of the drug preparation. We enhance drug formulations assuring the fitting of our premix medicines to the current standard of care.

 

Innovating Anaesthesia

innovating-anaesthesia

Surgical procedures invasivity or duration reduction and increased cost pressures on health systems are leading to a shift toward day surgery. Modern short and medium acting local anesthetics are our One Day Surgery proposal to adapt the length and the conditions of anaesthesia to the novel surgical needs, allowing patients same day safe discharge.

We offer tailored solutions that cover various durations of action to address different surgical needs.

one-day-surgery

 

Pain science

painscience

Pain science represents our effort towards a continuous improvement of pain management therapies. These analgesics are primarily used to manage pain in perioperative settings, while also addressing acute and chronic pain of various origins and intensity.

Our portfolio includes a wide range of opioid and non-opioid products, innovative combination of active principles alongside the most established and historically used molecules.

 

Enhance Intrathecal Therapy

enhance-intrathecal-theraphy

Enhance Intrathecal Therapy is our promise to improve care in the neuromodulation. We develop novel drugs and make available life-changing medicines to the largest number of patients and health care providers world-wide.

 

Business strategy

Agile. International. High-performing.

 

Every year we reliably supply millions of doses of improved therapies across a wide range of therapeutic classes.

We currently market over 250 products globally, with an active pipeline of new ones always on the way. To manage the daily challenges we are facing as an industrial company and leverage opportunities of growth, we have adopted two different business models.

 

 

In Switzerland, Germany and Austria our specialized national sales teams directly promote and market our products.

Worldwide, we deliver our top medicines through a consolidated network of strategic international partners.

market

Value proposition

Sintetica delivers its distinctive value proposition through:

  • Continuous innovation based on deep understanding of medical needs

  • Privileged connection to all Swiss hospitals

  • Quality without compromises on the entire production

  • Flexible production with no stock-out guaranteed

  • Strategic partnerships along the entire value chain on shared values

  • Agile, empowered organization based on responsibility and merit

All our medicines are manufactured and controlled under strict quality and safety measures, meeting the highest Swiss, European, US and international standards. Sintetica boasts a state-of-the-art, FDA-approved production facility in Mendrisio (Couvet site inspection in Q3 2022) with low saturation and unrivalled manufacturing know-how.

Innovation

The Company has a proven track-record of innovation, leveraging on:

  • An experienced R&D department with 20+ dedicated professionals (more than 15% of the total workforce of our HQ), which have developed a portfolio of 14 patents over the last years

  • A full-fledged regulatory department, with a solid track record in different countries (high trust score with FDA) and an average of 50+ marketing authorizations p.a. completed over the last years

  • A proven track record of innovation with a visible pipeline of new launches in Europe, the US and the rest of the world between 2023 and 2025

Recognizing the importance of innovation, we constantly invest in the latest technologies and continuous employee training in order to support the scientific and industrial processes and to be quickly responsive to the latest medical discoveries and requests of the market.

prod

Corporate Social Responsibility

We strive to develop a culture in which respect is sovereign, lines of communications are opened, great talent is recognized and encouraged and individual success depends solely on personal merit and performance. Sintetica makes a great effort to be a positive member of the community everywhere it operates directly and is focused on minimizing the environmental impact of its operations by reducing its carbon footprint and natural resources demand.

respect-1

Sharing Culture

Openness to people and to the world is a distinctive hallmark of Sintetica’s culture. In placing value on people, Sintetica sees the expression and foundation of its own culture and identity. We encourage and support human diversity in all its forms as an expression of richness and as a source of long-term development. We seek in every way to facilitate all forms of inclusion and encourage social and cultural contamination, promoting an inclusive environment that stimulates everyone's participation and encourages the exchange of ideas and perspectives.

people

People

Our people are our biggest asset. That’s why we aim to create an environment where solidarity, respect for the individual, open communication and passion for our work will unleash the potential of all our people. We want our colleagues to be engaged, inspired and motivated by shared values and ambitions.

environment

Environment

We are committed to environmental protection across the product lifecycle, from R&D, through manufacturing, marketing and ultimately disposal. We strive to minimize the environmental impact of our operations by reducing the carbon footprint and natural resource demands of our own and our suppliers' business activities.

office2

Ethics, Integrity & Quality

a-great-place

A great place to work

Our ambition is to be a great place to work. This means we place emphasis to improving our people every day lifestyle and environment sustainability.

Headquarter
Via Penate 5
6850 Mendrisio
Switzerland

Tel. +41 91 640 42 50
info@sintetica.com

Report adverse reactions

Couvet (NE)
Rue des Iles 4B
2108 Couvet
Switzerland

Tel. +41 32 864 93 93

Baar (ZG)

Orders:
orderch@sintetica.com

Product information:
infoch@sintetica.com

Complaints:
complaintch@sintetica.com

International

Orders:
info@sintetica.com

Product information:
info@sintetica.com

Complaints:
complaint@sintetica.com

Germany
Sintetica GmbH
Albersloher Weg 11
48155 Münster

Tel. +49 251 / 91 59 65-0
kontakt@sintetica.com
Go to website

United Kingdom

Medical information enquiries: medinfo@sintetica.co.uk
Tel: +44 20 4537 4504

General enquiries: enquiries@sintetica.co.uk
Tel: +44 20 3693 2740


This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.